Quest Diagnostics Free Cash Flow 2010-2023 | DGX
Quest Diagnostics annual/quarterly free cash flow history and growth rate from 2010 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Quest Diagnostics free cash flow for the quarter ending December 31, 2023 was 864.00, a year-over-year.
- Quest Diagnostics free cash flow for the twelve months ending December 31, 2023 was , a year-over-year.
- Quest Diagnostics annual free cash flow for 2023 was $0.864B, a 34.25% decline from 2022.
- Quest Diagnostics annual free cash flow for 2022 was $1.314B, a 28.2% decline from 2021.
- Quest Diagnostics annual free cash flow for 2021 was $1.83B, a 15.31% increase from 2020.
| Quest Diagnostics Annual Free Cash Flow |
| 2023 |
864.00 |
| 2022 |
1,314.00 |
| 2021 |
1,830.00 |
| 2020 |
1,587.00 |
| 2019 |
843.00 |
| 2018 |
817.00 |
| 2017 |
923.00 |
| 2016 |
823.00 |
| 2015 |
558.00 |
| 2014 |
636.00 |
| 2013 |
421.00 |
| 2012 |
1,005.00 |
| 2011 |
734.00 |
| 2010 |
912.65 |
| 2009 |
830.49 |
| Quest Diagnostics Quarterly Free Cash Flow |
| 2023-12-31 |
864.00 |
| 2023-09-30 |
409.00 |
| 2023-06-30 |
307.00 |
| 2023-03-31 |
-33.00 |
| 2022-12-31 |
1,314.00 |
| 2022-09-30 |
1,127.00 |
| 2022-06-30 |
743.00 |
| 2022-03-31 |
417.00 |
| 2021-12-31 |
1,830.00 |
| 2021-09-30 |
1,493.00 |
| 2021-06-30 |
1,021.00 |
| 2021-03-31 |
645.00 |
| 2020-12-31 |
1,587.00 |
| 2020-09-30 |
1,208.00 |
| 2020-06-30 |
437.00 |
| 2020-03-31 |
164.00 |
| 2019-12-31 |
843.00 |
| 2019-09-30 |
667.00 |
| 2019-06-30 |
464.00 |
| 2019-03-31 |
228.00 |
| 2018-12-31 |
817.00 |
| 2018-09-30 |
673.00 |
| 2018-06-30 |
352.00 |
| 2018-03-31 |
107.00 |
| 2017-12-31 |
923.00 |
| 2017-09-30 |
682.00 |
| 2017-06-30 |
383.00 |
| 2017-03-31 |
154.00 |
| 2016-12-31 |
823.00 |
| 2016-09-30 |
600.00 |
| 2016-06-30 |
360.00 |
| 2016-03-31 |
106.00 |
| 2015-12-31 |
558.00 |
| 2015-09-30 |
380.00 |
| 2015-06-30 |
220.00 |
| 2015-03-31 |
-4.00 |
| 2014-12-31 |
636.00 |
| 2014-09-30 |
416.00 |
| 2014-06-30 |
247.00 |
| 2014-03-31 |
16.00 |
| 2013-12-31 |
421.00 |
| 2013-09-30 |
287.00 |
| 2013-06-30 |
150.00 |
| 2013-03-31 |
-2.00 |
| 2012-12-31 |
1,005.00 |
| 2012-09-30 |
684.44 |
| 2012-06-30 |
334.73 |
| 2012-03-31 |
131.27 |
| 2011-12-31 |
734.00 |
| 2011-09-30 |
439.85 |
| 2011-06-30 |
141.46 |
| 2011-03-31 |
121.59 |
| 2010-12-31 |
912.65 |
| 2010-09-30 |
642.17 |
| 2010-06-30 |
359.54 |
| 2010-03-31 |
199.45 |
| 2009-12-31 |
830.49 |
| 2009-09-30 |
520.07 |
| 2009-06-30 |
187.56 |
| 2009-03-31 |
233.15 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$15.460B |
$9.252B |
|
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
|
